INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 43h ago
House PTR3h ago
SEC 13F3h ago
Robinhood Chain3h ago

Most active filers · 30d

  1. 01FWFogarty Patrick W0B / 206S206 trades$1.10M
  2. 02Kurtz George0B / 202S202 trades$48.06M
  3. 03SPSaba Capital Management, L.P.67B / 19S · 11 late86 trades$22.22M
  4. 04NYNissan Yitzhak82B / 0S · 79 late82 trades$2.61M
  5. 05ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  6. 06AJAllaire Jeremy0B / 50S50 trades$4.26M
  7. 07Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  8. 08SJSheena Jonathan0B / 45S45 trades$3.01M
  9. 09CMCannon-Brookes Michael35B / 0S35 trades$11.72M
  10. 10SLSpeiser Michael L0B / 35S35 trades$14.00M

Cluster activity · 60d

  1. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  2. BUYMTDRMatador Resources CoNov 5 – Nov 189 insiders$1.02M
  3. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 168 insiders$42.58M
  4. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  5. SELLMGNIMAGNITE, INC.Nov 5 – Nov 198 insiders$2.81M
  6. SELLIBEXIBEX LtdNov 9 – Nov 167 insiders$3.36M
  7. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  8. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M

Form 4 transactions

74,191 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
4
Dines DanielDirector, CEO and Chairman, 10% Owner
PATHUiPath, Inc.
Open-market sale · 10b5-1 plan
SELL$740K
45.0K sh
Dec 29, 2025
Page 1608 of 1855
← PrevNext →
Dec 29, 2025
traded Dec 29, 2025
+0d
SEC Form 4

Evidence

4
RM
Rizik MatthewDirector
RKTRocket Companies, Inc.
Open-market sale · 10b5-1 plan
SELL$49K
2,500 sh
Dec 24, 2025Dec 29, 2025
traded Dec 24, 2025
+5dSEC Form 4

Evidence

4
RM
Rizik MatthewDirector
RKTRocket Companies, Inc.
Open-market sale · 10b5-1 plan
SELL$47K
2,500 sh
Dec 23, 2025Dec 29, 2025
traded Dec 23, 2025
+6dSEC Form 4

Evidence

3
WL
Wu LeiDirector, Chief Executive Officer, 10% Owner
GCTGigaCloud Technology Inc
Derivative conversion · 10b5-1 plan
C—
800.0K sh
Dec 26, 2025Dec 29, 2025
traded Dec 26, 2025
+3dSEC Form 4

Evidence

2
SB
Slowe Christopher BrianChief Technology Officer
RDDTReddit, Inc.
Derivative conversion · 10b5-1 plan
C—
12.0K sh
Dec 22, 2025Dec 29, 2025
traded Dec 22, 2025
+7dSEC Form 4

Evidence

1
BS
Beatty Jonathan SMD, Head of Advisor Services
SCHWSCHWAB CHARLES CORP
Option exercise · 10b5-1 plan
M—
2,000 sh
Dec 23, 2025Dec 29, 2025
traded Dec 23, 2025
+6dSEC Form 4

Evidence

1
SS
Skates SpenserDirector, Chief Executive Officer, 10% Owner
AMPLAmplitude, Inc.
Derivative conversion · 10b5-1 plan
C—
42.7K sh
Dec 24, 2025Dec 29, 2025
traded Dec 24, 2025
+5dSEC Form 4

Evidence

0
SB
Slowe Christopher BrianChief Technology Officer
RDDTReddit, Inc.
Derivative conversion · 10b5-1 plan
C—
12.0K sh
Dec 22, 2025Dec 29, 2025
traded Dec 22, 2025
+7dSEC Form 4

Evidence

0
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
281.3K sh
Dec 24, 2025Dec 29, 2025
traded Dec 24, 2025
+5dSEC Form 4

Evidence

0
SB
Slowe Christopher BrianChief Technology Officer
RDDTReddit, Inc.
Option exercise · 10b5-1 plan
M—
12.0K sh
Dec 22, 2025Dec 29, 2025
traded Dec 22, 2025
+7dSEC Form 4

Evidence

0
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
281.3K sh
Dec 24, 2025Dec 29, 2025
traded Dec 24, 2025
+5dSEC Form 4

Evidence

0
RM
Rizik MatthewDirector
RKTRocket Companies, Inc.
Open-market sale · 10b5-1 plan
SELL$48K
2,500 sh
Dec 26, 2025Dec 29, 2025
traded Dec 26, 2025
+3dSEC Form 4

Evidence

54
CM
Chaouki Steven MDirector
MAIAMAIA Biotechnology, Inc.
Open-market purchase
BUY$56K
40.8K sh
Dec 22, 2025Dec 23, 2025
traded Dec 22, 2025
+1dSEC Form 4

Evidence

54
LY
Louie Ngar YeeDirector
MAIAMAIA Biotechnology, Inc.
Open-market purchase
BUY$111K
81.7K sh
Dec 22, 2025Dec 23, 2025
traded Dec 22, 2025
+1dSEC Form 4

Evidence

51
FF
Flannery FionaDirector
GFNEW GERMANY FUND INC
Open-market purchase
BUY$10K
872 sh
Dec 15, 2025Dec 23, 2025
traded Dec 15, 2025
+8dSEC Form 4

Evidence

48
ZN
Zojwalla NaseemChief Medical Officer
OLMAOlema Pharmaceuticals, Inc.
Open-market sale
SELL$2.75M
99.5K sh
Dec 23, 2025Dec 23, 2025
traded Dec 23, 2025
+0dSEC Form 4

Evidence

48
ZN
Zojwalla NaseemChief Medical Officer
OLMAOlema Pharmaceuticals, Inc.
Open-market sale
SELL$2.80M
100.0K sh
Dec 22, 2025Dec 23, 2025
traded Dec 22, 2025
+1dSEC Form 4

Evidence

48
ZN
Zojwalla NaseemChief Medical Officer
OLMAOlema Pharmaceuticals, Inc.
Open-market sale
SELL$1.60M
57.1K sh
Dec 19, 2025Dec 23, 2025
traded Dec 19, 2025
+4dSEC Form 4

Evidence

47
SS
Smith StanDirector
MAIAMAIA Biotechnology, Inc.
Open-market purchase
BUY$78K
57.2K sh
Dec 22, 2025Dec 23, 2025
traded Dec 22, 2025
+1dSEC Form 4

Evidence

47
CM
Chaouki Steven MDirector
MAIAMAIA Biotechnology, Inc.
Open-market purchase
BUY$50K
40.8K sh
Dec 22, 2025Dec 23, 2025
traded Dec 22, 2025
+1dSEC Form 4

Evidence

46
LY
Louie Ngar YeeDirector
MAIAMAIA Biotechnology, Inc.
Open-market purchase
BUY$100K
81.7K sh
Dec 22, 2025Dec 23, 2025
traded Dec 22, 2025
+1dSEC Form 4

Evidence

45
SM
Sentonas MichaelPRESIDENT
CRWDCrowdStrike Holdings, Inc.
Open-market sale
SELL$5.50M
11.5K sh
Dec 22, 2025Dec 23, 2025
traded Dec 22, 2025
+1dSEC Form 4

Evidence

44
MC
Myles David C.CH. DISCOV. & NON-CLIN DEV OFF
OLMAOlema Pharmaceuticals, Inc.
Open-market sale
SELL$1.33M
43.7K sh
Dec 19, 2025Dec 23, 2025
traded Dec 19, 2025
+4dSEC Form 4

Evidence

42
SA
Saha AnuragCHIEF ACCOUNTING OFFICER
CRWDCrowdStrike Holdings, Inc.
Open-market sale
SELL$734K
1,530 sh
Dec 22, 2025Dec 23, 2025
traded Dec 22, 2025
+1dSEC Form 4

Evidence

41
ZN
Zojwalla NaseemChief Medical Officer
OLMAOlema Pharmaceuticals, Inc.
Open-market sale
SELL$374K
12.9K sh
Dec 19, 2025Dec 23, 2025
traded Dec 19, 2025
+4dSEC Form 4

Evidence

40
HE
Ho EmilyChief Accounting Officer
SNOWSnowflake Inc.
Open-market sale
SELL$240K
1,072 sh
Dec 23, 2025Dec 23, 2025
traded Dec 23, 2025
+0dSEC Form 4

Evidence

40
AN
Armagno NinaDirector
RKLBRocket Lab Corp
Open-market sale · 10b5-1 plan
SELL$873K
12.4K sh
Dec 19, 2025Dec 23, 2025
traded Dec 19, 2025
+4dSEC Form 4

Evidence

40
WH
Williams Wesley HastieDirector
CIFRCipher Digital Inc.
Open-market sale
SELL$802K
49.9K sh
Dec 19, 2025Dec 23, 2025
traded Dec 19, 2025
+4dSEC Form 4

Evidence

38
YA
Yartz Laurel A.Chief Human Resources Officer
LAKELAKELAND INDUSTRIES INC
Open-market purchase
BUY$11K
1,350 sh
Dec 22, 2025Dec 23, 2025
traded Dec 22, 2025
+1dSEC Form 4

Evidence

37
JN
Joseph NelsonPFO, PAO & Treasurer
CCIFCarlyle Credit Income Fund
Open-market purchase
BUY$5,640
1,200 sh
Dec 22, 2025Dec 23, 2025
traded Dec 22, 2025
+1dSEC Form 4

Evidence

36
BE
Batill EricGeneral Counsel
CHPTChargePoint Holdings, Inc.
Open-market sale
SELL$21K
2,976 sh
Dec 23, 2025Dec 23, 2025
traded Dec 23, 2025
+0dSEC Form 4

Evidence

36
VD
Vice John DavidCRO
CHPTChargePoint Holdings, Inc.
Open-market sale
SELL$6,425
919 sh
Dec 23, 2025Dec 23, 2025
traded Dec 23, 2025
+0dSEC Form 4

Evidence

36
SC
Singh Jagdeep CACCXO
CHPTChargePoint Holdings, Inc.
Open-market sale
SELL$34K
4,832 sh
Dec 23, 2025Dec 23, 2025
traded Dec 23, 2025
+0dSEC Form 4

Evidence

36
KM
Khetani MansiCFO
CHPTChargePoint Holdings, Inc.
Open-market sale
SELL$28K
3,943 sh
Dec 23, 2025Dec 23, 2025
traded Dec 23, 2025
+0dSEC Form 4

Evidence

36
AN
Armagno NinaDirector
RKLBRocket Lab Corp
Open-market sale · 10b5-1 plan
SELL$310K
4,462 sh
Dec 19, 2025Dec 23, 2025
traded Dec 19, 2025
+4dSEC Form 4

Evidence

35
MN
Mac Ban Ryan NorrisChief Revenue Officer
CFLTConfluent, Inc.
Open-market sale
SELL$91K
3,053 sh
Dec 23, 2025Dec 23, 2025
traded Dec 23, 2025
+0dSEC Form 4

Evidence

35
BE
Baratz Alan EDirector, President & CEO
QBTSD-Wave Quantum Inc.
Open-market sale · 10b5-1 plan
SELL$23.91M
793.7K sh
Dec 22, 2025Dec 23, 2025
traded Dec 22, 2025
+1dSEC Form 4

Evidence

35
SS
Smith StanDirector
MAIAMAIA Biotechnology, Inc.
Open-market purchase
BUY$70K
57.2K sh
Dec 22, 2025Dec 23, 2025
traded Dec 22, 2025
+1dSEC Form 4

Evidence

35
PK
Phan KongChief Accounting Officer
CFLTConfluent, Inc.
Open-market sale
SELL$136K
4,545 sh
Dec 22, 2025Dec 23, 2025
traded Dec 22, 2025
+1dSEC Form 4

Evidence

34
MC
Myles David C.CH. DISCOV. & NON-CLIN DEV OFF
OLMAOlema Pharmaceuticals, Inc.
Open-market sale
SELL$190K
6,046 sh
Dec 19, 2025Dec 23, 2025
traded Dec 19, 2025
+4dSEC Form 4

Evidence